Liraglutide Delayed Type 2 Diabetes in Obese Patients with Prediabetes
Treatment with liraglutide was associated with 6.1% weight loss and reduced diabetes risk by nearly 80%.
Treatment with liraglutide was associated with 6.1% weight loss and reduced diabetes risk by nearly 80%.
In an early trial, patients lost an average of 37% of their excess weight in 4 months.
Two genetic variants are associated with heightened brain reward responses to foods high in fat and sugar.
Mothers with a high-fat diet may program their offspring for increased weight.
New data link hypothalamic gliosis with higher BMI and increased insulin resistance.
Weight, metabolic health, and overall quality of life improved 3 years after bariatric surgery.
Despite high engagement, a cell phone intervention did not increase weight loss.
Children of Latino parents with high stress levels are twice as likely to be obese.
Noninvasive brain stimulation may help decrease caloric intake and promote weight loss.
One night of sleep deprivation may be as detrimental as 6 months on a high-fat diet.